All-trans retinoic acid shifts rosiglitazone-induced adipogenic differentiation to osteogenic differentiation in mouse embryonic fibroblasts

Rosiglitazone (RSG) is a potent drug used in the treatment of insulin resistance; however, it is associated with marked skeletal toxicity. RSG-induced osteoporosis may contribute to the promotion of adipogenic differentiation at the expense of osteogenic differentiation in bone marrow stromal cells....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Med
Main Authors: Shao, Ying, Chen, Qian-Zhao, Zeng, Yu-Hua, Li, Yang, Ren, Wen-Yan, Zhou, Lin-Yun, Liu, Rong-Xin, Wu, Ke, Yang, Jun-Qing, Deng, Zhong-Liang, Yu, Yu, Sun, Wen-Juan, He, Bai-Cheng
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2016
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5117762/
https://ncbi.nlm.nih.gov/pubmed/27779644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2016.2782
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados